Tag results:

lymphocytes

Impaired HA-Specific T Follicular Helper Cell and Antibody Responses to Influenza Vaccination Are Linked to Inflammation in Humans

[eLife] By studying the breadth of anti-hemagglutinin (HA) IgG, serum cytokines, and B and T cell responses by flow cytometry before and after influenza vaccination, investigators showed that formation of circulating T follicular helper cells was associated with high-titre antibody responses.

An Organoid-Based Screen for Epigenetic Inhibitors That Stimulate Antigen Presentation and Potentiate T Cell-Mediated Cytotoxicity

[Nature Biomedical Engineering] Researchers reported a high-throughput screen based on the functional interaction of mouse- or patient-derived breast tumour organoids and tumor-specific cytotoxic T cells for the identification of epigenetic inhibitors that promote antigen presentation and potentiate T cell-mediated cytotoxicity.

Single-Cell Analysis of the Human Pancreas in Type 2 Diabetes Using Multi-Spectral Imaging Mass Cytometry

[Cell Reports] Investigators analyzed over two million cells from 16 pancreata obtained from donors with type 2 diabetes and 13 pancreata from age-similar non-diabetic controls.

Muscle-Specific Programmed Cell Death 5 Deletion Attenuates Cardiac Aging

[International Journal of Cardiology] Researchers revealed that programmed cell death 5 (Pdcd5) deficiency attenuated cardiac aging by reducing cellular senescence and apoptosis, and increasing Parkin-mediated mitophagy, likely through p53.

Peripheral Leukemia Burden at Time of Apheresis Negatively Affects the Clinical Efficacy of CART19 in Refractory or Relapsed B-ALL

[Molecular Therapy-Methods & Clinical Development] Scientists retrospectively analyzed 143 patients treated with CART19 to evaluate the effect of peripheral leukemia burden at time of apheresis.

Quantification of Cell-Free DNA for the Analysis of CD19-CAR-T Cells during Lymphoma Treatment

[Molecular Therapy-Methods & Clinical Development] Cell-free DNA isolated from 74 blood samples of 12 patients during lymphoma treatment with the anti-CD19 CAR-T cell product axicabtagene ciloleucel were analyzed.

Popular